Vascularity demonstrated by doppler ultrasound and immunohistochemistry in invasive ductal carcinoma of the breast
Tóm tắt
Vascularity is an important determinant of a tumour's ability to grow and disseminate. Breast tumour vascularity can be determined with doppler ultrasound (US) and by counting the vessels microscopically (microvascular density — MVD). The biologic characteristics of tumours based on their vascularity have not been extensively studied. Preoperative US was performed on 207 patients with invasive ductal breast carcinomas (IDC). MVD was assessed immunohistochemically using polyclonal antisera against factor VIII and the proliferation rate was measured with Ki-67 polyclonal antisera. Histologic tumour characteristics and oestrogen receptor (ER) status were determined. Thermography was performed on 174 of the patients. Twenty-five percent of IDC demonstrated US-vascularity. US-vascular tumours were more likely to be node positive, and had a higher mitotic rate than avascular cancers. US-vascularity was more common in tumours with MVD greater than 80 vessels/250x field than those with fewer vessels. The proliferation rate, histologic grade III, and nuclear grade III were higher and ER positivity lower, but the differences were not statistically significant. US-vascular cancers were associated with significantly more thermographic abnormalities. The cancer recurrence rate at three years was higher in patients with vascular cancers although the difference was not statistically significant. US appears to be a simple, non-invasive method of identifying vascular cancers associated with factors indicating a poor prognosis.
Tài liệu tham khảo
Folkman J: Tumour angiogenesis.In: Mendelsohn J, Howley PM, Israel MA, Liotta LA (eds) The Molecular Basis of Cancer. WB Saunders, pp 206–232, 1995
Gasparini G, Harris AL: Clinical importance of the determination of tumour angiogenesis in breast carcinoma: much more than a new prognostic tool. J Clin Oncol 13:765–782, 1995
Adler DD, Carson PL, Rubin JM, Quinn-Reid D: Dopplerultrasound color flow imaging in the study of breast cancer: Preliminary findings. Ultrasound Med Biol 16:553–559, 1990
Bergonzi M, Calliada F, Passamonti C, Campani R, Bottinelli O, Genovese E, Bozzetti E, Corsi G, Leoni P, Bozzini A: Color doppler in the echographic evaluation of breast nodules. Radiol Med 79:178–181, 1990
Cosgrove DO, Bamber JC, Davey JB, McKinna JA, Sinnett HD: Color doppler signals from breast tumors. Work in progress. Radiology 176:175–180, 1990
Dixon JM, Walsh J, Paterson D, Chetty U: Colour doppler ultrasonography studies of benign and malignant breast lesions. Br J Surg 79:259–260, 1992
Weidner N, Semple JP, Welch WR, Folkman J: Tumour angiogenesis and metastasis-correlation in invasive breast carcinoma. New Engl J Med 324:1–8, 1991
Gerdes J, Schwab U, Stein H: Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation. Int J Cancer 31:13–20, 1983
Le Doussal V, Tubiana-Hulin M, Friedman S, Hacene K, Spyratos F, Brunet M: Prognostic value of histologic grade nuclear components of Scarff-Bloom-Richardson (SBR). An improved score modification based on a multivariate analysis of 1262 invasive ductal carcinomas. Cancer 64: 1914–1921, 1989
Elston CW, Ellis IO: Pathologic prognostic factors in breast cancer. I. The value of histologic grade in breast cancer: Experience from a large study with long-term follow-up. Histopathol 19:403–410, 1991
Hsu SM, Raine L: The use of avidin biotin-peroxidase complex (ABC) in diagnostic and research pathology.In: DeLessis RA (ed) Advances in Immunohistochemistry in Diagnostic and Research Pathology. Masson, New York, 1984, pp 31–42
Barbareschi M, Girlando S, Mauri FM, Forti S, Eccher C, Mauri FA, Tongi R, Palma PD, Doglion C: Quantitative growth fraction evaluation with MIB1 and Ki67 antibodies and breast carcinomas. Amer J Clin Pathol 102:171–175, 1994
Dawson AE, Norton JA, Weinberg DS: Comparative assessment of proliferation and DNA content in breast carcinoma by image analysis and flow cytometry. Amer J Pathol 136:1115–1124, 1993
Chaney JV: Comparison of manual counting with image analysis using proliferating cell nuclear antigen to estimate S-phase in infiltrating ductal carcinoma of the breast. Amer J Clin Pathol 98:347, 1993
Zafrani B, Leroyer A, Fourquet A, Laurent M, Trophilme D, Validire P, Sastre-Garau X: Mammographically detected ductal carcinoma in situ of the breast analyzed with a new classification. A study of 127 cases: correlation with estrogen and progesterone receptors, p53 and erbB-2 proteins and proliferative activity. Sem in Diag Pathol 11: 208–214, 1994
Hanna WM, Kahn HJ, Chapman JAW: The correlation of Ki67 growth factor and ERICA in breast cancer. Mod Pathol 5:220–223, 1992
Sterns EE, Zee B: Thermography as a predictor of prognosis in cancer of the breast. Cancer 67:1678–1680, 1991
Hsieh C-Y, Wu C-C, Chen T-M, Chen C-A, Chen C-L, Wang J-F, Chang C-F, Hsieh F-J: Clinical significance of intratumoral blood flow in cervical carcinoma assessed by color doppler ultrasound. Cancer 75:2518–2522, 1995
Bosari S, Lee AK, DeLellis RA, Wiley BD, Heatley GJ, Silverman ML: Microvessel quantitation and prognosis in invasive breast carcinoma. Hum Pathol 23:755–761, 1992
Fox SB, Leek RD, Smith K, Hollyer J, Greenall M, Harris AL: Tumour angiogenesis in node-negative breast carcinomas — relationship with epidermal growth factor receptor, estrogen receptor, and survival. Breast Cancer Res Treat 29:109–116, 1994
Gasparini G, Weidner N, Bevilacqua P, Maluta S, Dalla Palma P, Caffo O, Barbareschi M, Boracchi P, Marubini E, Pozza: Tumour microvessel density, p53 expression, Tumour size, and peritumoral lymphatic vessel invasion are relevant prognostic markers in node-negative breast carcinoma. J Clin Oncology 12:454–466, 1994
Horak ER, Leek R, Klenk N, LeJeune S, Smith K, Stuart N, Greenall M, Stepniewska K, Harris AL: Angiogenesis, assessed by platelet/endothelial cell adhesion molecule antibodies, as indicator of node metastases and survival in breast cancer. Lancet 340:1120–1124, 1992
Sahin AA, Sneige N, Ordonez GN, Singletary E, Ayala A: Tumour angiogenesis detected by Ulex europaeus agglutinin 1 lectin (UEA 1) and factor VIII immunostaining in node-negative breast carcinoma (NNBC) treated by mastectomy: prediction of tumour recurrence. Mod Pathol 6:19a, 1993
Sneige N, Singletary E, Sahin A, El-Naggar A: Multiparametric analysis of potential prognostic factors in node negative breast cancer patients. Mod Pathol 5:18a, 1992
Toi M, Kashitani J, Tominaga T: Tumour angiogenesis is an independent prognostic indicator in primary breast carcinoma. Internat J Cancer 55:371–374, 1993
Costello A, McCann A, Carney D, Dervan P: Lack of prognostic significance of microvessel density in lymph node negative breast carcinoma. Ann Meeting Abs Internat Acad Pathol, 1995
Hall NR, Fish DE, Hunt N, Goldin RD, Guillou PJ, Monson JR: Is the relationship between angiogenesis and metastasis in breast cancer real? Surg Oncol 1:223–229, 1992
Kaldjian EP, Jin L, Davenport RD, Lloyd RV: Immunohistochemical analysis of hormone receptors, Tumour vascularity, and proliferative activity in paraffin-embedded specimens. Applied Immmunohistochem 1:31–38, 1993
Marley E, Frost A, Tabbara S: The significance and reproducibility of microvessel quantitation in infiltrating lobular carcinoma of the breast. Ann Meeting Abs Internat Acad Pathol, 1995
Tan LK, Lesser ML, Arroyo CD, Rosen PP: Intratumoral microvessel density and prognosis in T2N0M0 breast carcinoma. Ann Meeting Abs Internat Acad Pathol, 1995
Costello P, McCann A, Carney D, Dervan PA: Prognostic significance of microvessel density in lymph node negative breast carcinoma. Hum Pathol 26:1181–1184, 1995
Goulding H, Nik Abdoul Rahid NF, Robertson JF, Bell JA, Elston CW, Blamey RW, Ellis IO: Assessment of angiogenesis in breast carcinoma: An important factor in prognosis? Hum Pathol 26:1196–1200, 1995
Siitonen SM, Haapasalo HK, Rantala IS, Helin HJ, Isola JJ: Comparison of different immunohistochemical methods in the assessment of angiogenesis: Lack of prognostic value in a group of 77 selected node-negative breast carcinomas. Mod Pathol 8:745–752, 1995
Barbareschi M, Weidner N, Gasparini G, Morelli L, Forti S, Eccher C, Fina P, Caffo O, Leonardi E, Mauri F, Bevilacqua P, Palma P: Microvessel density quantification in breast carcinomas. Assessment by light microscopy vs. a computeraided image analysis system. Appl Immunohistochem 3:75–84, 1995
Monschke F, Muller WU, Winkler U, Streffer C: Cell proliferation and vascularization in human breast carcinomas. Int J Cancer 49:812–815, 1991
Vartanian RK, Weidner N: Correlation of intratumoral endothelial cell proliferation with microvessel density (tumour angiogenesis) and tumour cell proliferation in breast carcinoma. Amer J Pathol 144:1188–1194, 1994
McGurrin JF, Doria MI, Dawson PJ, Karrison T, Stein HO, Franklin WA: Assessment of tumour cell kinetics by immunohistochemistry in carcinoma of breast. Cancer 59:1744–1750, 1987
Sterns EE, Zee B, SenGupta S, Saunders F: Thermography: Its relation to pathologic characteristics, vascularity, proliferation rate and survival in invasive ductal carcinoma of the breast. Cancer (in press)